Home
All Journals
Expert Opinion on Pharmacotherapy
List of Issues
Volume 6, Issue 12

Expert Opinion on Pharmacotherapy

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Pharmacotherapy, Volume 6, Issue 12 (2005)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Pharmacotherapy, Volume 6, Issue 12 (2005)

See all volumes and issues

Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Volume 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Review

Article

Pharmacogenomics and therapeutic prospects in Alzheimer’s disease

Ramón Cacabelos

Pages: 1967-1987

Published online: 03 Oct 2005

AbstractforPharmacogenomics and therapeutic prospects in Alzheimer’s disease | References | PDF (278.5 KB)

256 Views
45 CrossRef citations
0Altmetric

Article

Do adrenergically active drugs have a role in the first-line treatment of attention-deficit/hyperactivity disorder?

Philip Hazell

Pages: 1989-1998

Published online: 03 Oct 2005

AbstractforDo adrenergically active drugs have a role in the first-line treatment of attention-deficit/hyperactivity disorder? | References | PDF (151.7 KB)

69 Views
2 CrossRef citations
0Altmetric

Article

Pharmacotherapy of postpartum depression: current practice and future directions

Oleg V Tcheremissine & Lori M Lieving

Pages: 1999-2005

Published online: 03 Oct 2005

AbstractforPharmacotherapy of postpartum depression: current practice and future directions | References | PDF (127.9 KB)

100 Views
0 CrossRef citations
0Altmetric

Article

Pharmacological testing of anisocoria

Aileen A Antonio-Santos, Ronel N Santo & Eric R Eggenberger

Pages: 2007-2013

Published online: 03 Oct 2005

AbstractforPharmacological testing of anisocoria | References | PDF (718.8 KB)

631 Views
13 CrossRef citations
0Altmetric

Article

Pharmacogenomics in lung cancer: an analysis of DNA repair gene expression in patients treated with platinum-based chemotherapy

Rosario García-Campelo, Guillermo Alonso-Curbera, LM Antón Aparicio & Rafael Rosell

Pages: 2015-2026

Published online: 03 Oct 2005

AbstractforPharmacogenomics in lung cancer: an analysis of DNA repair gene expression in patients treated with platinum-based chemotherapy | References | PDF (805.4 KB)

111 Views
19 CrossRef citations
0Altmetric

Article

Resistance to antiplatelet drugs: current status and future research

Udaya S Tantry, Kevin P Bliden & Paul A Gurbel

Pages: 2027-2045

Published online: 03 Oct 2005

AbstractforResistance to antiplatelet drugs: current status and future research | References | PDF (284.1 KB)

144 Views
57 CrossRef citations
0Altmetric

Article

Eisenmenger syndrome: medical prevention and management strategies

Werner Budts

Pages: 2047-2060

Published online: 03 Oct 2005

AbstractforEisenmenger syndrome: medical prevention and management strategies | References | PDF (218.1 KB)

78 Views
8 CrossRef citations
0Altmetric

Drug Evaluation

Article

Rasagiline in the pharmacotherapy of Parkinson’s disease – a review

Olivier Rascol

Pages: 2061-2075

Published online: 03 Oct 2005

AbstractforRasagiline in the pharmacotherapy of Parkinson’s disease – a review | References | PDF (231.1 KB)

232 Views
23 CrossRef citations
0Altmetric

Article

Olanzapine: a critical review of recent literature

Peter F Buckley

Pages: 2077-2089

Published online: 03 Oct 2005

AbstractforOlanzapine: a critical review of recent literature | References | PDF (186 KB)

94 Views
10 CrossRef citations
0Altmetric

Article

Aripiprazole

W Wolfgang Fleischhacker

Pages: 2091-2101

Published online: 03 Oct 2005

AbstractforAripiprazole | References | PDF (163.7 KB)

418 Views
72 CrossRef citations
0Altmetric

Article

Acamprosate in the treatment of alcohol dependence

Barbara J Mason

Pages: 2103-2115

Published online: 03 Oct 2005

AbstractforAcamprosate in the treatment of alcohol dependence | References | PDF (192.4 KB)

136 Views
29 CrossRef citations
0Altmetric

Article

Meloxicam: a reappraisal of pharmacokinetics, efficacy and safety

Brian J Gates, Trang T Nguyen, Stephen M Setter & Neal M Davies

Pages: 2117-2140

Published online: 03 Oct 2005

AbstractforMeloxicam: a reappraisal of pharmacokinetics, efficacy and safety | References | PDF (266.5 KB)

577 Views
61 CrossRef citations
0Altmetric

Key Paper Evaluation

Article

Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity?

VAN GAAL LF, SCHEEN AJ, ZIEGLER O, RÖSSNER S for the RIO-EUROPE STUDY GROUP: Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet (2005) 365:1389-1397.

Sheila A Doggrell

Pages: 2141-2144

Published online: 03 Oct 2005

AbstractforIs the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity? | References | PDF (89.1 KB)

41 Views
0 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

Rizwana Parveen et al.

Review Article | Published online: 28 May 2024

Promising immunomodulators for management of substance and alcohol use disorders

Amanda M. Acuña et al.

Review Article | Published online: 28 May 2024

Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals

Krystyna Dobrowolska et al.

Review Article | Published online: 27 May 2024

Recent advances in pharmacological management of attention-deficit/hyperactivity disorder: moving beyond stimulants

Ann Childress

Review Article | Published online: 27 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Pharmacotherapy (Vol.6, Iss.12, 2005)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?